Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Israeli (TA) Pharma Industry Analysis
UpdatedJun 30, 2022
DataAggregated Company Financials
Companies8
- 7D3.3%
- 3M-17.2%
- 1Y-35.0%
- YTD-13.7%
In the last week, the Pharma industry is up 3.3%, with Rekah Pharmaceutical Industry leading the way, up 8.4%. Meanwhile, Nextgen Biomed actually underperformed within the industry, shrinking 5.6% in the last week. However, the industry is down 35% over the past year. Looking forward, earnings are forecast to grow by 91% annually.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 01 Jul 2022 | ₪1.7b | ₪731.4m | -₪119,323,194.00 | 45x |
| Sun, 29 May 2022 | ₪1.8b | ₪731.4m | -₪117,214,504.00 | 43.7x |
| Tue, 26 Apr 2022 | ₪1.8b | ₪669.4m | -₪122,093,632.00 | 36.9x |
| Thu, 24 Mar 2022 | ₪1.9b | ₪598.9m | -₪111,250,724.00 | 48x |
| Sat, 19 Feb 2022 | ₪1.9b | ₪598.9m | -₪110,989,917.00 | 47.5x |
| Mon, 17 Jan 2022 | ₪2.0b | ₪598.9m | -₪95,834,215.00 | 51x |
| Wed, 15 Dec 2021 | ₪2.0b | ₪559.8m | -₪169,685,797.00 | 49x |
| Fri, 12 Nov 2021 | ₪2.2b | ₪522.6m | -₪155,277,310.00 | 29.7x |
| Sun, 10 Oct 2021 | ₪2.2b | ₪522.6m | -₪147,005,403.00 | 28x |
| Tue, 07 Sep 2021 | ₪2.4b | ₪515.1m | -₪150,674,423.50 | 28.3x |
| Thu, 05 Aug 2021 | ₪2.4b | ₪499.0m | -₪147,462,423.50 | 26.6x |
| Sun, 09 May 2021 | ₪2.5b | ₪466.6m | -₪189,880,366.50 | 24.9x |
| Wed, 10 Feb 2021 | ₪2.3b | ₪442.0m | -₪259,485,185.20 | 25.1x |
| Tue, 03 Nov 2020 | ₪1.7b | ₪384.0m | -₪288,523,540.95 | 29.5x |
| Fri, 07 Aug 2020 | ₪1.8b | ₪328.9m | -₪330,614,786.00 | 41.1x |
| Thu, 30 Apr 2020 | ₪1.6b | ₪292.5m | -₪291,139,946.80 | 52.8x |
| Sun, 02 Feb 2020 | ₪1.1b | ₪254.4m | -₪156,223,485.00 | 86.7x |
| Wed, 06 Nov 2019 | ₪1.1b | ₪232.0m | -₪39,702,894.00 | 43.4x |
| Sat, 10 Aug 2019 | ₪1.3b | ₪203.2m | -₪37,809,169.80 | 46.7x |
Median PE Ratio
49.2x
Current Industry PE
- Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically.
- The industry's 3-year average PS ratio 4.6x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 53% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Israeli Pharma compare with similar industries?
| IL Market | 1.61% | |
| Healthcare | 0.90% | |
| Pharma | 3.30% | |
| Pharma | 3.30% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INCR InterCure | ₪20.75 | 2.4% +₪21.7m | -9.1% | PE63.1x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪2.58 | 10.4% +₪10.9m | -52.7% | PS3.1x | |
| SEMG Seach Medical Group | ₪2.68 | 9.3% +₪7.7m | -50.5% | PE13.6x | |
| CSURE Cannassure Therapeutics | ₪0.23 | 5.0% +₪911.0k | -67.7% | PS1.2x |
